ORGANOS NORWAY
Closed at November 13th, 2026
Vitenskapelig forskning og analyse i farmasøytisk industri.
Organization
- Operation time
- 5 years
- - Jan 6, 2021 to Nov 13, 2026
- Type
- Norwegian division of foreign business enterprise
- VAT registered
- No
- Number of employees
- 0
Financials
- Total equity 2025
- 66,350
- NOK
Last update: Nov 13, 2026
Management
No available data
Ownership
No available data
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total operating income | 0 | 441,740 | 859,774 |
Annual Total Result | 0 | 22,477 | 43,873 |
Total assets | 1,301,514 | 1,301,514 | 859,774 |
Total liabilities | 1,235,164 | 1,235,164 | 815,901 |
Total equity | 66,350 | 66,350 | 43,873 |
P&L
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total operating income | 0 | 441,740 | 859,774 |
Total operating costs | 0 | 412,551 | 803,527 |
Operating result | 0 | 29,189 | 56,247 |
Financial income/costs | 0 | -290 | 0 |
Profit before tax | 0 | 28,899 | 56,247 |
Total tax & extraordinary income/cost | 0 | 6,422 | 12,374 |
Annual Total Result | 0 | 22,477 | 43,873 |
Balance overview
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total fixed assets | 1,301,514 | 0 | 0 |
Total current assets | 0 | 1,301,514 | 859,774 |
Total assets | 1,301,514 | 1,301,514 | 859,774 |
Short term debt | 1,235,164 | 6,422 | 201,615 |
Long term debt | 0 | 1,228,742 | 614,286 |
Total liabilities | 1,235,164 | 1,235,164 | 815,901 |
Contributed capital | 0 | 0 | 0 |
Retained earnings | 66,350 | 66,350 | 43,873 |
Total equity | 66,350 | 66,350 | 43,873 |
Total equity and liabilities | 1,301,514 | 1,301,514 | 859,774 |
Classification
21st company classification
BETA
Small company
Type of organization
Norwegian division of foreign business enterprise
Standard industrial classification